Anaphylactic shock (AS) is characterised by excessive vasodilatation and massive fluid shifts resulting in marked hypovolaemia and systemic hypotension leading to severe tissue hypoperfusion. We have previously shown that blood flow and oxygen delivery are decreased rapidly in skeletal muscle, as well as in the brain, after the onset of anaphylactic shock 1,2 . Persistent energy consumption results in a decrease in tissue oxygen pressures (PtiO 2) and substrate depletion through anaerobic glycolysis which leads within minutes to complete failure of cellular energy production 1 . Therefore, both rapid restoration of systemic haemodynamics and microcirculatory perfusion should be considered as optimal therapeutic goals. This is usually achieved by a combination of adrenaline and volume expansion. However, there is no solid evidence for the choice of one type of resuscitation fluid over another in SUMMARy Anaphylactic shock is a rare, but potentially lethal complication, combining life-threatening circulatory failure and massive fluid shifts. Treatment guidelines rely on adrenaline and volume expansion by intravenous fluids, but there is no solid evidence for the choice of one specific type of fluid over another. Our purpose was to compare the time to achieve target mean arterial pressure upon resuscitation using adrenaline alone versus adrenaline with different resuscitation fluids in an animal model and to compare the tissue oxygen pressures (PtiO 2 ) with the various strategies. Twenty-five ovalbumin-sensitised Brown Norway rats were allocated to five groups after anaphylactic shock induction: vehicle (CON), adrenaline alone (AD), or adrenaline with isotonic saline (AD+IS), hydroxyethyl starch (AD+HES) or hypertonic saline (AD+HS). Time to reach a target mean arterial pressure value of 75 mmHg, cardiac output, skeletal muscle PtiO 2 , lactate/pyruvate ratio and cumulative doses of adrenaline were recorded. Non-treated rats died within 15 minutes. The target mean arterial pressure value was reached faster with AD+HES (median: 10 minutes, range: 7.5 to 12.5 minutes) and AD+IS (median: 17.5 minutes, range: 5 to 25 minutes) versus adrenaline alone (median: 25 minutes, range: 20-30 minutes). There were also reduced adrenaline requirements in these groups. The skeletal muscle PtiO 2 was restored only in the AD+HES group. Although direct extrapolation to humans should be made with caution, our results support the combined use of adrenaline and volume expansion for resuscitation from anaphylactic shock. When used with adrenaline the most effective fluid was hydroxyethyl starch, whereas hypertonic saline was the least effective.
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Since randomised clinical trials involving anaphylaxis in humans are particularly difficult to conduct, we decided to conduct our study in an experimental animal model of AS. The primary aim of our study was to compare time to achieve target mean arterial pressure (MAP) using adrenaline alone versus adrenaline with different volume expanders. The secondary aim was to compare the effect of the different strategies on cardiac output (CO) and skeletal muscle perfusion, as well as metabolism. We used the cumulative doses of adrenaline required to reach a target MAP value as a proxy for volume expansion requirements because of the difficulties in directly assessing the volume-expanding capabilities of the three solutions.
MATERIALS AND METHODS

Animals and Sensitisation Protocol
All animal procedures and care were performed in accordance with the European Communities Council Directive of November 24, 1986 (Approval No. 86/609/EEC). Our study was also conducted according to the official recommendation of the French Ministry of Agriculture (Paris, France) and the recommendations of the Helsinki Declaration. Ten-week-old Brown Norway rats weighing 250 to 300 g (janvier, Le Genest-St-Isle, France) were used for these experiments. Animals were kept under standard conditions (temperature 21°±1°C; lights from 6:00am to 6:00pm) and given a standard diet (A04; UAR, Villemoisson-sur-Orge, France) and water (Aquaclear; Culligan, Northbrook, IL) ad libitum. Rats were sensitised by subcutaneous administration of 1 mg intravenous (IV) chicken egg albumin, avalbumin, (OVA; Sigma-Aldrich, Saint-Quentin Fallavier, France) and 4 mg aluminum hydroxide (OHAl; Sigma, Saint-Louis, USA) diluted in 1 ml 0.9% saline solution on days 0, 4 and 14, as described previously 1, 11 .
Surgical procedure, measurement of haemodynamic variables, tissue oxygen partial pressure and microdialysis in skeletal muscle
The surgical procedure was performed on day 21 following sensitisation. Anaesthesia was induced with 3.0% isoflurane. The trachea was intubated and the lungs were mechanically ventilated with 100% oxygen using a Harvard Rodent respirator (model 683, Harvard Apparatus, Cambridge, MA). Tidal A flexible Clark-type polarographic oxygen electrode (outer diameter: 0.5 mm; length: 200 mm) connected to a computer-supported Licox system (GMS, Mielkendorf, Germany) was introduced in one of the quadriceps muscles for PtiO 2 measurement. In the other quadriceps muscle, a linear flexible microdialysis probe (membrane, polyarylethersulfone; membrane length, 10 mm; outer diameter, 0.5 mm; molecular weight cut-off, 20 kd, CMA Microdialysis AB, Solna, Sweden) was inserted as described previously 1 . The probe was connected to a microinjection pump (CMA 107 Microdialysis pump, Solna, Sweden) and perfused with Ringer's solution at a flow rate of 2 μl/minute -1 . Dialysate collections were started 10 minutes before shock induction with 10-minute sampling periods. All samples were collected in microtubes and analysed by the CMA 600 microdialysis analyser (CMA 600, Solna, Sweden).
Induction of shock and treatment with volume expansion and adrenaline
After a twenty minute stabilisation period, animals were randomly assigned to five different groups. Except for the non-treatment group that received ovalbumin alone (CON), all the other animals were resuscitated with either adrenaline alone (AD) or adrenaline with one of three different volume expanders: 1) isotonic saline solution 30 ml/kg 1 (AD+IS); 2) hydroxyethyl starch solution (HES 130/0.4; VOLUVEN®, Fresenius Kabi, Louviers, France) 20 ml/kg (AD+HES); 3) hypertonic sodium chloride solution (7.5%) 4 ml/kg (AD+HS). The volume of fluid infused was chosen according to the most recent guidelines published in the field of anaphylaxis, which recommend different volumes of infusion based on their different volume expansion capacity 3, 12 .
Anaphylactic shock was induced by intravenous injection of 1 mg of ovalbumin. The first bolus of 2.5 μg of adrenaline was injected three minutes after shock induction and a second bolus was injected at 5 minutes. Then, owing to the severity of our model, a continuous infusion of adrenaline 10 μg/kg/minute was initiated, as this is usually recommended in most guidelines as an alternative to repeated bolus administration. When MAP had reached the target value of 75 mmHg and had remained stable for a 10 minute period, the infusion rate of adrenaline was progressively decreased to avoid an excessive increase in MAP (after completion of fluid expansion). Fluid resuscitation was initiated immediately after the first bolus injection of adrenaline. Using an electronic infusion pump, the perfusion rate of the volume expander was maintained at 1 ml/minute (about 4 ml/ kg/minute).
In all animals, MAP, CO and PtiO 2 in skeletal muscle were recorded at different time points: intravenous injection of 1 mg of ovalbumin (prior to shock induction), at 1, 2.5, 5, 7.5, 10, 12.5 and 15 minutes after shock induction; then every 5 minutes until the end of the experiment. Blood gas analysis was performed in each animal before shock induction and at the end of the experiment.
Statistical analysis
Data were analysed with the Statview 5.0 software (Deltasoft, Meylan, France). Results are expressed as mean ± standard error of the mean (SEM). Inter- For each animal, the time to achieve target mean arterial pressure (75 mmHg) was recorded and expressed as median and range. Significance was assumed when P<0.05.
RESULTS
Twenty-five ovalbumin-sensitised Brown Norway rats were randomly allocated into five groups. For all measured variables, baseline values in the five groups did not differ significantly during the stabilisation period. As all animals from the CON group died within 15 minutes, data from microdialysis and plasma biochemistry were not obtained from this group.
In this model of lethal AS, the rats in the CON group died within 15 minutes, whereas all treatments were able to extend survival time. Time course profiles for MAP ( Figure 1A) were different among the groups. After shock induction, MAP decreased similarly in all groups. From five minutes onwards MAP increased progressively but in a different manner according to the treatment. With AD alone, time to target MAP value was significantly longer (median: 25 min, range: 20-30 min) as compared to all other AD + volume expansion groups except for the AD+HS (median: 30 minutes, range: 20 to 60 minutes). A MAP of 75 mmHg was achieved with AD+HES at 10 minutes (median: 10, range: 7.5 to 12.5 minutes), followed by AD+IS at 17.5 minutes (median: 17.5, range: 5 to 25 minutes), AD at 25 minutes and AD+HS at 30 minutes ( Figure 2 ). The MAP response to adrenaline was significantly higher in AD+HES from 15 minutes (onset of decrease of adrenaline infusion rate) to 30 minutes as compared with other treatment groups (P<0.05, Figure 1A ). Cumulative adrenaline doses were significantly lower in AD+HES and AD+IS compared to AD and AD+HS. The MAP response to adrenaline could therefore be classified in order of potency: AD+HES > AD+IS > AD > AD+HS (Figure 4) .
In all treated groups, CO decreased to 40% of baseline values within three minutes. A rapid and significant increase in CO ( Figure 1B ) was observed after volume expansion with AD+IS and AD+HES. Cardiac output recovery was 90 % and 60 % of basal values respectively but the time course profile did not differ statistically significantly. A slower increase was observed in the AD group, reaching 60% of baseline at 35 minutes, whereas CO remained at about 50% of basal in the AD+HS group.
PtiO 2 values ( Figure 3A ) decreased immediately after the induction of shock, then time course profiles differed according to treatment groups. PtiO 2 values in the AD+HES group increased up to 90% of baseline values by 20 minutes then progressively decreased to 60% of baseline. In the AD+IS and AD groups, the decrease of PtiO 2 reached a plateau at 30% and 15% of baseline, respectively. A continuous decrease was observed in the AD+HS group, resulting in PtiO 2 values almost at zero by the end of the experiment. A progressive increase in lactate/pyruvate ratios was observed in all treatment groups; however the increase was less in the AD+HES group ( Figure 3B ). Continuous infusion of adrenaline 10 μg/kg / minute was initiated immediately after the first bolus and maintained to allow MAP values to reach 75 mmHg in all treated groups. When the MAP goal was reached and had remained stable during a 10 minute period, the adrenaline infusion rate was progressively decreased to avoid excessive increase in MAP values (Figure 4 ). The perfusion rate in the AD+HES group and AD+IS group was progressively decreased from 15 minutes and 20 minutes, respectively, after the onset of anaphylactic shock. The cumulative doses of adrenaline in the AD+HES (131.9±10.4 μg) and in the AD+IS (141.9±6.8 μg) groups were significantly lower than in the AD+HS (163.6±7.9 μg) and AD (165.3±2.4 μg) groups.
The time courses of the main biochemical and haematology variables are summarised in Table 1 . Following shock induction, the concentration of haemoglobin increased in all treatment groups; however, this increase was higher in the AD group (P<0.05). At the end of experiment, the concentration of chloride and sodium ions were significantly increased in the AD+HS group. The concentrations of lactate were significantly increased except in the AD+IS group and glucose was significantly increased in the AD+HES group compared to the other groups.
DISCUSSION
Although direct extrapolation to humans should be made with caution, our results support the combined use of adrenaline and volume expansion for resuscitation from AS. When used with adrenaline the most effective fluid was HES, whereas HS was the least effective and was associated with highly deleterious effects on tissue oxygenation. Interestingly, (i) IS (median: 17.5, range: 5 to 25 minutes) and HES (median: 10, range: 7.5 to 12.5 minutes, P>0.05 vs AD+IS) were equally fast and faster than HS (median: 30 minutes, range: 20 to 60 minutes, P<0.05 vs AD+HES or AD+IS) to reach the target MAP value and increase CO; (ii) adrenaline requirements to preserve MAP values of 75 mmHg were reduced with IS and HES; (iii) better arterial blood gases and lower circulating lactate and glucose levels were obtained with IS; (iv) only AD+HES restored PtiO 2 and preserved aerobic metabolism in skeletal muscle. These results underline the importance of volume expansion with adrenaline in the treatment of anaphylactic shock and suggest that nature of the volume expander is also important.
Several methodological issues deserve more detailed explanations. The first concerns the fact that modified fluid gelatins were not investigated in the present study. Epidemiologic studies have showed that HES was at low risk of causing anaphylactic reactions (0.058%) compared with gelatins (0.345%) 13, 14 . Therefore, gelatins have been excluded in recent European guidelines, which favour the use of HES in anaphylaxis 3 . However, in view of the recent withdrawal of HES from many markets, another possible choice would be the use of albumin.
The second concerns the volumes of the different volume expanders that were investigated. It was recently shown in septic patients that haemodynamic resuscitation was faster after volume expansion with HES than with isotonic saline 15 . The volume of fluid that should be infused for anaphylactic shock resuscitation remains poorly defined. The necessary volume of saline is either not mentioned 5 or varies between 20 ml/kg 16 and 30 ml/kg 3 . Some authors even recommend volume of fluids as high as 50 ml/kg, a goal that may be difficult to achieve in a short period of time 17 . We chose a median dose of 30 ml/kg of saline. As recent studies in septic shock have emphasised that volume equivalence of HES may be far less than previously thought (with a ratio crystalloid/ colloid volume between 1.2 and 1.5) 15,18 , we chose a volume of HES of 20 ml/kg. The volume of 4 ml/kg for HS has been the most studied for this solution 9, 19, 20 and is the upper limit for use in many countries, including France. Because the volume-expanding equivalents are difficult to handle and because resuscitation of AS is performed with a combination of adrenaline and volume expansion, we chose a pragmatic design by (i) estimating the efficacy of resuscitation on time to target MAP (a clinically available and obviously important haemodynamic goal); (ii) evaluating the efficacy of different combinations of adrenaline and volume expanders on both haemodynamic goals (e.g. cardiac output and skeletal muscle oxygenation) and the requirements of cumulative adrenaline doses (once again a clinically relevant measurement).
Resuscitation with HES and adrenaline resulted in the shortest time to reach the target MAP value, an obviously critical haemodynamic endpoint for the most rapid correction of CO and skeletal muscle microcirculation abnormalities. The increased skeletal muscle PtiO 2 values in the AD+HES group were most likely caused by the increase in intravascular volume, CO and skeletal microvascular perfusion.
Indeed, it has been demonstrated that HES has a therapeutic advantage by exerting an inhibitory effect on the local ischaemia-reperfusion injury and on systemic leukocyte activation and on post-ischaemic microvascular dysfunction 21, 22 . However, part of the differences we observed could also be related to the reduction of adrenaline doses when the primary MAP target was reached. Adrenaline has been considered useful in the treatment of anaphylactic shock since as early as 1925 23 and retrospective analyses have indicated that adrenaline and volume expansion are effective treatments for anaphylaxis occurring under anaesthesia [24] [25] [26] . A relatively high dose of adrenaline was chosen for bolus administration in this study. This dose was determined according to doseresponse curves previously established in this model 11 . However, high catecholamine concentrations (either therapeutic or due to endogenous release) can have adverse cardiovascular consequences, including direct catecholamine-induced myocardial dys-Table1
Biochemistry and haematology variables in the no volume expansion (AD), isotonic saline (AD+IS), hydroxyethyl starch (AD+HES), hypertonic saline (AD+HS) and non-treated (CON) groups.
Group AD AD+IS AD+HES AD+HS 27, 28 , increased myocardial workload resulting from increased afterload, ischaemic chest pain (in awake patients) and electrocardiography changes consistent with myocardial ischaemia in the absence of documented coronary artery disease 29 . Our experimental design corresponded to a situation where the possibility to decrease the infusion rates of adrenaline (once the target MAP of 75 mmHg had been reached) was a proxy for the restoration of circulating volume. The observed reduction in adrenaline infusion rates adds further support to the use of HES above IS or HS in the treatment of anaphylaxis.
In this experimental rat model of lethal AS, HES was significantly more efficient than HS when combined with adrenaline administration. This is consistent with other studies in hypovolaemic shock that have demonstrated lower tissue oxygenation upon resuscitation with HS [30] [31] [32] . Our initial hypothesis was that HS could be of potential interest during AS because it is associated with a smaller volume load and thus, would have allowed more rapid correction of the haemodynamic abnormalities. It has been reported previously that each ml of HS administered mobilises an additional 7 ml of free water from the interstitial and intracellular spaces respectively into the intravascular compartment 33 . However, the infused volume of HS solution should be limited because of the possibilities of hypernatraemia and hyperchloraemia 34 .
In our model, 4 ml/kg of HS resulted in significantly longer times to reach the target MAP values and did not restore CO or correct skeletal muscle hypoxia. Skeletal muscle hypoxia (sharp decrease of PtiO 2 ) and hypoperfusion without inhibition of cellular metabolism, resulted in anaerobic glycolysis, followed by depletion of substrates 1 , as confirmed by the lactate/ pyruvate ratios and the concentration of glucose in our study ( Figure 2 and Table 1 ). Four ml/kg HS may be an insufficient volume to increase intravascular volume by itself. Moreover, the increased permeability of the microcirculation, induced by AS, probably limited the osmotic effect of hypertonic crystalloid and colloid solutions because plasma molecules are lost to the interstitial compartment 35 . As a result, based on haemoglobin (Hb) values changes throughout the study, none of the strategies applied were found to fully restore circulating blood volume. This effect is probably more pronounced for small crystalloid molecules than for large colloid molecules (e.g. HES, thus opening the possibility that natural colloids such as albumin could be useful). The lack of correction of the increased haemoglobin values in the AD+HS group (as compared to intragroup baseline values and to the other groups) clearly supports this interpretation (Table 1 ).
In addition, it is possible that HS had additional detrimental effects. One of them could be related to the high chloride load, as illustrated in Table 1 . Hyperchloraemia produces acidosis by excessive increase of plasma chloride concentration relative to the plasma sodium concentration 36 . This was the case in our experiments in which the AD+HS group had the lowest pH values associated with hypernatraemia. The resulting hyperchloraemic acidosis can lead to a decrease in cardiac contractility [37] [38] [39] [40] [41] . HS has also been reported to decrease systemic vascular resistance [42] [43] [44] . This effect may be interesting in hypovolaemic shock where systemic vascular resistance is high. However, in the setting of severe vasodilatation, the decrease in cardiac afterload induced by HS may partially offset the benefit of volume expansion. This could explain the delayed and limited increase in MAP and CO we observed when compared with the other treatment groups ( Figure 1A) .
Within the timeframe of this experiment, IS was expected to have a slightly lower volume expansion effect compared to HES 45 . Nevertheless, the differences in cardiac output ( Figure 1B) were minimal between AD+IS and AD+HES groups. Despite this, the AD+IS group was characterised by lower initial MAP and PtiO 2 values. The lower lactate values in animals resuscitated with AD+IS (as compared to AD+HES) could be due to lack of skeletal muscle reperfusion as suggested by the persistence of low PtiO 2 values, combined with decreased glycolysis, as previously demonstrated by our group 1 . On the other hand, the larger increase in circulating lactate values observed in the AD+HES group might have resulted from insufficient tissue perfusion. Nevertheless, the increased PtiO 2 values are consistent with more efficient skeletal muscle reperfusion.
Our study has several limitations. First of all, any extrapolation of our results obtained in this severe experimental model of anaphylactic shock to clinical practice should be performed with caution. However, one should also consider that present guidelines concerning the treatment of AS rely mainly on expert advice in the absence of any available controlled experimental or clinical studies. We chose to infuse different volumes at the same rate, leading to different infusion durations. First, all infusions of volume expanders were terminated at the tenth minute, a small delay as compared with our experiment duration. Second, one of the major interests of isotonic saline alternatives is precisely to shorten infusion duration 15 . Therefore, it was not considered appropriate to standardise this duration. 772 K. TAjIMA, F. ZHENG ET AL Anaesthesia and Intensive Care, Vol. 41, No. 6, November 2013 Another possible limitation relates to the relatively limited number of animals involved in each group. This would have limited our capacity to demonstrate real differences between treatment groups if they existed, particularly concerning the findings we observed concerning a faster increase in MAP, CO and decrease in adrenaline requirement in the AD+HES group, or the more limited increase in Hb values indicating a better restoration of circulating blood volume in the AD+IS group.
CONCLUSION
Our results demonstrate that resuscitation of experimental AS in an animal model was fastest when adrenaline was used with concurrent volume expansion rather than alone. Of the expansion fluids, HES and IS were superior to HS, whereas only HES restored PtiO 2 and preserved aerobic metabolism in skeletal muscle. Hypertonic saline appeared to be inappropriate for treatment of anaphylactic shock in this model. While a clinical trial would be particularly difficult to organise, our experimental results provide support for current guidelines on the management of anaphylactic shock, but also suggest that colloids (including possibly natural colloids such as albumin) could be more suitable than crystalloids as the firstline volume expanding fluid in severe anaphylaxis.
